Theratechnologies Inc T.TH

Alternate Symbol(s): THTX

Healthcare Biotechnology

Theratechnologies Inc. is a Canada-based clinical-stage biopharmaceutical company. The Company is focused on the development and commercialization of therapies addressing unmet medical needs. It markets prescription products for people with human immunodeficiency viruses (HIV) in the United States. The Company's research pipeline focuses on specialized therapies addressing unmet medical needs in HIV, nonalcoholic steatohepatitis (NASH) and oncology. Its medicines include Trogarzo and EGRIFTA SV (tesamorelin for injection). Trogarzo (ibalizumab-uiyk) injection is a long-acting monoclonal antibody which binds to domain 2 of the CD4 T cell receptors. EGRIFTA SV (tesamorelin for injection) is approved in the United States for the reduction of excess abdominal fat in people with HIV who have lipodystrophy. Its portfolio includes Phase I clinical trial of sudocetaxel zendusortide (TH1902), a novel peptide-drug conjugate (PDC), in patients with advanced ovarian cancer.

TSX:TH - Post by User

Theratechnologies Inc > AGM predictions

<< Previous

Bullboard Posts

Next >>

Comment by Mannequinon May 06, 2024 5:07pm

53 Views

Post# 36025791

RE:RE:AGM predictions

I think you're going to see a shake up probably this week.

Lee430 wrote: Unfortunately I don’t think enough owners will rally to terminate our employee (Dawn) despite leading us into technical bankruptcy.

Trogarzon wrote: So any predictions for the AGM outcome on Thursday. Will we assist to a sequel of last year with Dawn sitting next to our wonder boy putting a deathrow face on once again. Minus 94% over 5 years... like SPCEO said so well... Technical bankrupcy. Anyway, hope we make it to a better place and that it's under the helm of other BOD and management... sincerely. Hope they go away.